Allergan
In Wallace Weitz's portfolio · Weitz Investment Management
Ticker AGN
Not in the portfolio as of Q3 2026. Every quarter it shows up in a Weitz Investment Management 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q1 2019 | Sell | 0 | |
| Q4 2018 | Reduce 24% | 383,236 | 2.3% |
| Q3 2018 | Reduce 22% | 505,270 | 3.9% |
| Q2 2018 | Reduce 3% | 650,041 | 4.6% |
| Q1 2018 | Add 3% | 670,399 | 4.8% |
| Q4 2017 | Add 24% | 650,315 | 4.4% |
| Q3 2017 | Add 9% | 523,810 | 4.4% |
| Q2 2017 | Reduce 6% | 481,895 | 5.1% |
| Q1 2017 | Reduce 20% | 512,403 | 5.0% |
| Q4 2016 | Add 5% | 637,733 | 5.3% |
| Q3 2016 | Add 2% | 609,963 | 5.3% |
| Q2 2016 | Add 96% | 595,961 | 5.1% |
| Q1 2016 | Add 55% | 304,722 | 2.9% |
| Q4 2015 | Add 5% | 196,170 | 2.1% |
| Q3 2015 | Buy | 187,607 | 1.6% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.